View all available purchase options and get full access to this article.

The embolization particle market size is expected to reach US$ 9.25 billion by 2034 from US$ 2.67 billion in 2025, registering a strong CAGR of 14.80% during 2026–2034. Embolization particles are specialized medical materials used in minimally invasive procedures to block or reduce blood flow to targeted blood vessels. These products play an important role in treating tumors, vascular abnormalities, and other conditions requiring controlled vessel occlusion.

Increasing investment in healthcare infrastructure is strengthening market opportunities across developed and emerging economies. Hospitals are expanding interventional radiology departments, upgrading imaging systems, and investing in specialized catheterization facilities. These developments improve the availability of minimally invasive vascular treatments and support the adoption of advanced embolization devices. As healthcare systems strengthen their capabilities to diagnose and treat vascular disorders, demand for reliable and technologically advanced occlusion solutions is expected to increase.

Explore pregnancy possibilities after uterine fibroid embolization. Learn about post-procedure fertility, conception timeline, and reproductive health after UFE.

The peripheral embolization coils market size is projected to reach US$ 613.96 million by 2031, increasing from US$ 433.06 million in 2023. The market is expected to register a CAGR of 4.5% during 2023–2031, driven by the growing adoption of minimally invasive procedures, rising prevalence of vascular disorders, and increasing demand for advanced interventional radiology treatments. Peripheral embolization coils are medical devices used to block or reduce blood flow in targeted blood vessels to manage conditions such as aneurysms, vascular malformations, and internal bleeding.

Swiss J. Radiol. Nucl. Med. · Vol. 22 No. 1 · 2025-08-26 · DOI doi.org/10.59667/sjoranm.v22i1.16 · Bronchial artery embolization (BAE) is an established treatment for hemoptysis. While major complications are well documented, transient headaches during the procedure are rarely reported. Purpose…

Swiss J. Radiol. Nucl. Med. · Vol. 6 No. 1 · 2024-03-30 · DOI doi.org/10.59667/sjoranm.v6i1.12 · Persistent perfusion of an internal iliac artery aneurysm after endovascular aortic repair can be difficult to treat when the usual antegrade route is no longer available. We report a 90-year-old…

Instylla's Embrace® Hydrogel Embolic System has gained FDA approval for treating peripheral arterial bleeds, marking a significant advancement in embolization technology.

Swiss J. Radiol. Nucl. Med. · Vol. 27 No. 1 · 2026-01-30 · DOI doi.org/10.59667/sjoranm.v27i1.28 · Chronic hip pain due to osteoarthritis (OA) is a prevalent source of disability in older adults. While total hip arthroplasty (THA) remains the standard treatment for end-stage disease, many…

Swiss J. Radiol. Nucl. Med. · Vol. 14 No. 1 · 2024-12-30 · DOI doi.org/10.59667/sjoranm.v14i1.14 · Osteoarthritis (OA) is a widespread disorder which commonly impacts a significant portion of the population. Although most cases involve the knee joint, it can also affect the carpometacarpal joint…

Swiss J. Radiol. Nucl. Med. · Vol. 4 No. 1 · 2024-01-31 · DOI doi.org/10.59667/sjoranm.v4i1.12 · The management of an aneurysm or pseudoaneurysm, including decisions regarding how, when, and with what method it should be treated, must always be determined through interdisciplinary consensus…

Explore uterine artery embolization as a non-surgical treatment for adenomyosis that preserves your uterus and provides lasting relief from painful symptoms.

Background/Objectives: Chronic resistant migraine responds poorly to multiple classes of preventive therapy. The middle meningeal artery (MMA), along which nociceptive trigeminal fibers run, has been proposed as an interventional target. We report an interim feasibility and sa...

A case report from West China Second University Hospital describes a newborn with a giant congenital hemangioma and arteriovenous fistula on the right forearm whose severe pulmonary hypertension and